Bibliography
- WILSON SJ, BELLAMY MC, GIANNOUDIS PV: The safety and efficacy of the administration of recombinant activated Factor VII in major surgery and trauma patients. Expert Opin. Drug Sal: (2005) 4(3):557–570.
- RIOU B, BOFFARD K, WARREN B et al: Recombinant Factor VIIa (NovoSeven®) as adjunctive therapy for bleeding control in trauma - a randomized, placebo-controlled trial. Shock (2004) 21\(Suppl. 2):76–77 (Abstract 227).
- BOFFARD KD, WARREN B, IAU P et al:Decreased transfusion utilization and improved outcome associated with the use of recombinant Factor VIIa as an adjunct in trauma. J. Trauma (2004) 57:451 (Abstract 59). Presented at the American Association for the Surgery of Trauma, Hawaii, USA, October 2004.
- ROSSAINT R, BOFFARD KD, WARREN BL et at: Decreased transfusion utilization using recombinant Factor VIIa as an adjunct in trauma. Grit. Care Med. (2004) 30\(Suppl. 1):5199 (Abstract 771). Presented at the European Society of Intensive Care Medicine, Berlin, Germany, October 2004.
- COATS T, ROBERTS I, SHAKUR H: Antifibrinolytic drugs for acute traumatic injury. Cochrane Library (2005) Issue 3.